Innovating Works

NeurImmKisses

Financiado
Architecture of Peripheral Neuroimmune Circuits and Synapses
Maintenance of health requires the coordination of multiple cellular networks. For example, the immune and nervous systems cooperate to regulate tissue homeostasis. In agreement, our recent work demonstrates that innate lymphoid c... Maintenance of health requires the coordination of multiple cellular networks. For example, the immune and nervous systems cooperate to regulate tissue homeostasis. In agreement, our recent work demonstrates that innate lymphoid cells (ILC) integrate neuronal signals to control tissue health and immunity. These findings are provoking a paradigm shift in our understanding of the immune response, neuroimmune crosstalk and its potential therapeutic value. Nevertheless, the dynamics of neuroimmune modalities remain elusive, and progress in the field has been hindered by the lack of approaches to explore the identity and plasticity of neuroimmune interactions in vivo. Here, we hypothesise that dynamic circuitry codes orchestrate neuro-ILC2 interactions and disease outcomes. To test this hypothesis, we have developed a set of disruptive intercellular labelling neuroimmune toolboxes that we termed KISS and LIPSTIC, and which can probe the dynamics of neuro-ILC2 axes in vivo, with cellular specificity and single-cell resolution. Using these innovative platforms, we plan to unravel the architecture of pulmonary neuro-ILC2 circuits and to define cellular identities, outcomes, and plasticity at the neuroimmune interface. Sequentially, we propose to unravel unappreciated neuro-ILC2 synaptic communication and to define the ultrastructure of theses intercellular entities using high-resolution imaging. Finally, by conditionally harnessing the activity of synaptic neuronal partners during airway inflammation and infection, we will investigate their impact on ILC2, their environment, and on disease progression. Together, these experiments will tackle multiple facets of pioneer, frontier questions, bringing to bear an array of cutting-edge technologies to address and advance, with unprecedented mechanistic and conceptual detail, how the neuroimmune interactome unfolds, in health and disease. ver más
31/12/2028
4M€
Duración del proyecto: 67 meses Fecha Inicio: 2023-05-05
Fecha Fin: 2028-12-31

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-05
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
ERC-2022-ADG: ERC ADVANCED GRANTS
Cerrada hace 2 años
Presupuesto El presupuesto total del proyecto asciende a 4M€
Líder del proyecto
FUNDACAO D. ANNA DE SOMMER CHAMPALIMAUD E DR.... No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5